This preprint is under consideration at BMC Nephrology. A preprint is a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice.
Learn more about In Review
Research Article
Kimio Watanabe
St. Luke's International Hospital
Corresponding Author
License:
This work is licensed under a CC BY 4.0 License. Read Full License
Background There is no evidence on how to use the information from bioimpedance analysis (BIA) devices in clinical management, including setting of target dry weight (DW), or improving outcomes in hemodialysis (HD) patients.
Methods Here, we investigate preferable cut off values of fluid status (extracellular water/total body water ratio; ECW/TBW) detected by a new and more accurate BIA device (Seca®) in 78 HD patients.
Results Patients with an ECW/TBW of more than 45% and human atrial natriuretic peptide (HANP) value of > 50 pg/mL had a higher blood pressure and cardio-thoracic ratio on chest x-ray examination.
Conclusions Our results suggests that ECW/TBW of more than 45% and HANP value of > 50 pg/mL were overhydrated and had a worse prognosis.
Keywords
Bioimpedance analysis, Dry weight, Hemodialysis
Figure 1
Loading...
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
Peer Review Timeline
CURRENT STATUS: Under Review
Version 1
Posted 11 Mar, 2021
No community comments so far
Review #1 received
Received 07 Apr, 2021
Reviewer #1 agreed
On 07 Apr, 2021
Reviewer #2 agreed
On 07 Apr, 2021
Review #2 received
Received 07 Apr, 2021
Review #3 received
Received 07 Apr, 2021
Review #4 received
Received 07 Apr, 2021
Reviewer #3 agreed
On 07 Apr, 2021
Reviewer #4 agreed
On 07 Apr, 2021
Reviewer #5 agreed
On 07 Apr, 2021
Reviewers invited
Invitations sent on 07 Mar, 2021
Editor assigned
On 07 Mar, 2021
Editor invited
On 04 Mar, 2021
Submission checks complete
On 03 Mar, 2021
First submitted
On 23 Feb, 2021
Metrics
Comments: 0
PDF Downloads: ...
HTML Views: ...
Subject Areas
Urology & Nephrology
Learn more about our company.
This preprint is under consideration at BMC Nephrology. A preprint is a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice.
Learn more about In Review
Research Article
Kimio Watanabe
St. Luke's International Hospital
Corresponding Author
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
Peer Review Timeline
CURRENT STATUS: Under Review
Version 1
Posted 11 Mar, 2021
No community comments so far
Review #1 received
Received 07 Apr, 2021
Reviewer #1 agreed
On 07 Apr, 2021
Reviewer #2 agreed
On 07 Apr, 2021
Review #2 received
Received 07 Apr, 2021
Review #3 received
Received 07 Apr, 2021
Review #4 received
Received 07 Apr, 2021
Reviewer #3 agreed
On 07 Apr, 2021
Reviewer #4 agreed
On 07 Apr, 2021
Reviewer #5 agreed
On 07 Apr, 2021
Reviewers invited
Invitations sent on 07 Mar, 2021
Editor assigned
On 07 Mar, 2021
Editor invited
On 04 Mar, 2021
Submission checks complete
On 03 Mar, 2021
First submitted
On 23 Feb, 2021
Subject Areas
Urology & Nephrology
License:
This work is licensed under a CC BY 4.0 License. Read Full License
Background There is no evidence on how to use the information from bioimpedance analysis (BIA) devices in clinical management, including setting of target dry weight (DW), or improving outcomes in hemodialysis (HD) patients.
Methods Here, we investigate preferable cut off values of fluid status (extracellular water/total body water ratio; ECW/TBW) detected by a new and more accurate BIA device (Seca®) in 78 HD patients.
Results Patients with an ECW/TBW of more than 45% and human atrial natriuretic peptide (HANP) value of > 50 pg/mL had a higher blood pressure and cardio-thoracic ratio on chest x-ray examination.
Conclusions Our results suggests that ECW/TBW of more than 45% and HANP value of > 50 pg/mL were overhydrated and had a worse prognosis.
Figure 1
Loading...